Efficacy of Vitamin E Treatment for Hand-Foot Syndrome in Patients Receiving Capecitabine

被引：8
作者：
Yamamoto, Daigo [1 ]
Yamamoto, Chizuko [2 ]
Iwase, Satoru [3 ]
Kuroda, Yujiro [3 ]
Odagiri, Hiroki [4 ]
Nagumo, Yoshinori [5 ]
机构：
[1] Kansai Med Univ, Dept Surg, Osaka 5708507, Japan
[2] Seiko Hosp, Dept Internal Med, Osaka, Japan
[3] Tokyo Univ Hosp, Dept Palliat Med, Tokyo 113, Japan
[4] Hirosaki Univ, Dept Surg, Aomori, Japan
[5] Nagumo Clin, Breast Unit, Tokyo, Japan
来源：
BREAST CARE | 2010年 / 5卷 / 06期
关键词：
METASTATIC BREAST-CANCER; MULTICENTER PHASE-II; THERAPY; TOLERABILITY; MANAGEMENT; DOCETAXEL; TUMORS; TRIAL; SKIN;
D O I：
10.1159/000322660
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：415 / 416
页数：2
相关论文
共 20 条
  • [1] Expression and localization of thymidine phosphorylase/platelet-derived endothelial cell growth factor in skin and cutaneous tumors
    Asgari, MM
    Haggerty, JG
    McNiff, JM
    Milstone, LM
    Schwartz, PM
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 1999, 26 (06) : 287 - 294
  • [2] Blum JL, 2001, CANCER, V92, P1759, DOI 10.1002/1097-0142(20011001)92:7<1759::AID-CNCR1691>3.0.CO
  • [3] 2-A
  • [4] Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
    Blum, JL
    Jones, SE
    Buzdar, AU
    LoRusso, PM
    Kuter, I
    Vogel, C
    Osterwalder, B
    Burger, HU
    Brown, CS
    Griffin, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 485 - 493
  • [5] Blum JL., 2001, Eur J Cancer, V37, P190
  • [6] Capecitabine-Based Combination Therapy for Breast Cancer: Implications for Nurses
    Frye, Debra K.
    [J]. ONCOLOGY NURSING FORUM, 2009, 36 (01) : 105 - 113
  • [7] Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Fumoleau, P
    Largillier, R
    Clippe, C
    Dièras, V
    Orfeuvre, H
    Lesimple, T
    Culine, S
    Audhuy, B
    Serin, D
    Curé, H
    Vuillemin, E
    Morère, JF
    Montestruc, F
    Mouri, Z
    Namer, M
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (04) : 536 - 542
  • [8] Gressett Sarah M, 2006, J Oncol Pharm Pract, V12, P131, DOI 10.1177/1078155206069242
  • [9] Potential regional differences for the tolerability profiles of fluoropyrimidines
    Haller, Daniel G.
    Cassidy, Jim
    Clarke, Stephen J.
    Cunningham, David
    Van Cutsem, Eric
    Hoff, Paulo M.
    Rothenberg, Mace L.
    Saltz, Leonard B.
    Schmoll, Hans-Joachim
    Allegra, Carmen
    Bertino, Joseph R.
    Douillard, Jean-Yves
    Gustavsson, Bengt G.
    Milano, Gerard
    O'Connell, Michael
    Rustum, Youcef
    Tabernero, Josep
    Gilberg, Frank
    Sirzen, Florin
    Twelves, Chris
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) : 2118 - 2123
  • [10] Halliwell B, 1993, FREE RADICAL BIO MED, P188
12